"Gabriella is a key figure in the company and she has made an influential contribution to building our continuous expansion platform. Although I regret her choice to leave Bactiguard, I respect her decision to return to the financial industry. I want to thank Bactiguard CEO Anders Göransson said: "Thank her for her significant contribution to the company and wish her the best in the future. "

"My time at Bactiguard is both exciting and challenging. It is my honor to be able to participate in laying the foundation for the company's growth and transformation, and I believe Bactiguard will continue to consolidate its position as a leader in infection prevention. "Going forward", Bactiguard's Chief Financial Officer and Deputy CEO Gabriella Björknert Caracciolo said that he will join Söderberg & Partners as chief operating officer.

The recruitment process to find replacements will begin immediately.

This information is information that Bactiguard Holding AB (publ) is obliged to disclose in accordance with EU market abuse regulations. This information has been submitted and released through the agents of the following contacts at 08:00 on December 13, 2021.

For more information, please contact: Anders Göransson, CEO, Tel: +46 8 440 58 80  

About Bactiguard Bactiguard is a Swedish medical device company whose mission is to save lives. To achieve this mission, we develop and provide infection prevention solutions to reduce the risk of infection and the use of antibiotics. In this way, we save a lot of costs for medical care and society as a whole.

Bactiguard technology is based on a thin precious metal alloy coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard provides this technology through a license agreement and our BIP (Bactiguard Infection Protection) product portfolio. Through our authorized partner BD, urinary catheters using Bactiguard technology are the market leader in the United States and Japan, and in 2021, Zimmer Biomet launched the orthopedic trauma implant ZNN Bactiguard. Bactiguard's product portfolio also includes a line of non-alcoholic products for wound care and disinfection. It effectively kills microorganisms, and at the same time has biocompatibility and tissue friendliness.

Bactiguard is in a strong expansion stage in Europe, China, India, the Middle East and Southeast Asia through our own product portfolio and establishing licensing agreements in new therapeutic areas. Bactiguard has approximately 210 employees worldwide. Its headquarters and one of its three production facilities are located in Stockholm, and the other two are located in Malaysia. Bactiguard is listed on NASDAQ Stockholm.

Read more about Bactiguard www.bactiguard.com

https://news.cision.com/bactiguard-holding-ab--publ-/r/gabriella-bjorknert-caracciolo-has-today-announced-that-she-will-leave-the-role-as-cfo- and-deputy-ce,c3470888

https://mb.cision.com/Main/9686/3470888/1508889.pdf

https://news.cision.com/bactiguard-holding-ab--publ-/i/gabriella-bjorknert-caracciolo,c2991268

(c) 2021 Cision. all rights reserved. , Source press release-English